Preparation of inclusion complex of piroxicam with cyclodextrin by using supercritical carbon dioxide

Journal of Supercritical Fluids

Volumn 47, Issue 2, 2008, Pages 326-332

  Sauceau, Martial ^a   Rodier, Elisabeth ^a   Fages, Jacques ^a  

^a ECOLE DES MINES D ALBI CARMAUX   (France)

Author keywords

Complex; Cyclodextrin; Piroxicam; Supercritical carbon dioxide; Ternary agent

Indexed keywords

AMINO ACIDS; BIOCHEMISTRY; CARBON DIOXIDE; CYCLODEXTRINS; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; LASER INTERFEROMETRY; OXIDES; SCANNING; SILANES; WATER CONTENT;

COMPLEX; CYCLODEXTRIN; PIROXICAM; SUPERCRITICAL CARBON DIOXIDE; TERNARY AGENT;

SUPERCRITICAL FLUID EXTRACTION;

EID: 53649099033     PISSN: 08968446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.supflu.2008.07.006     Document Type: Article

References (65)

1. Fages J., Lochard H., Letourneau J.-J., Sauceau M., and Rodier E. Particle generation for pharmaceutical applications using supercritical fluid technology. Powder Tech. 141 (2004) 219-226
2. Jung J., and Perrut M. Particle design using supercritical fluids: literature and patent survey. J. Supercrit. Fluids 20 (2001) 179-219
3. H. Lochard, M. Sauceau, E. Rodier, J.-J. Letourneau, J. Fages, Use of RESS and SAS processes for powder generation of an active substance, Proc. 4th World Congress on Particle Technology, Sydney, Australia, 2002, on CD-ROM.
4. Stella V.J., and Rajewski R.A. Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 14 (1997) 556-567
5. Qi H., and Sikorski C. Controlled delivery using cyclodextrin technology. Pharm. Tech. Europe Nov. (2001) 17-27
6. Loftsson T., and Brewster M. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85 (1996) 1017-1025
7. Fenyvesi E., Vikmon M., Szeman J., Redenti E., Delcanale M., Ventura P., and Szejtli J. Interaction of hydroxy acids with β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 33 (1999) 339-344
8. Redenti E., Szente L., and Szejtli J. Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications. J. Pharm. Sci. 89 (2000) 1-8
9. Mura P., Maestrelli F., and Cirri M. Ternary systems of naproxen with hydroxypropyl-β-cyclodextrin and aminoacids. Int. J. Pharm. 260 (2003) 293-302
10. Piel G., Pirotte B., Delneuville I., Neven P., Llabres G., Delarge J., and Delattre L. Study of the influence of both cyclodextrins and l-lysine on the aqueous solubility of nimesulide; Isolation and characterization of nimesulide-l-lysine-cyclodextrin complexes. J. Pharm. Sci. 86 (1997) 475-480
11. Mammucari R., and Foster N.R. Dense gas technology and cyclodextrins: State of the art and potential. Curr. Org. Chem. 12 (2008) 476-491
12. Kamihira M., Asai T., Yamagata Y., Taniguchi M., and Kobayashi T. Formation of inclusion complexes between cyclodextrins and aromatic compounds under pressurized carbon dioxide. J. Ferment. Bioeng. 69 (1990) 350-353
13. F. Giordano, M. Rillosi, G.P. Bettinetti, A. Gazzaniga, M. Majewski, M. Perrut, Interaction of supercritical fluids with drug/cyclodextrin inclusion compounds and physical mixtures, in: Proc. 8th Int. Symposium on Cyclodextrins, 1996, pp. 193-196.
14. Van Hees T., Piel G., Evrard B., Otte X., Thunus L., and Delattre L. Application of supercritical carbon dioxide for the preparation of a piroxicam-β-cyclodextrin inclusion compound. Pharm. Res. 16 (1999) 1864-1870
15. Van Hees T., Barillaro V., Piel G., Bertholet P., Henry De Hassonville S., Evrard B., and Delattre L. Application of supercritical carbon dioxide for the preparation of drug-cyclodextrin inclusion compounds. J. Incl. Phenom. Macrocycl. Chem. 44 (2002) 271-274
16. Barillaro V., Piel G., Bertholet P., Henry de Hassonville S., Evrard B., and Delattre L. Inclusion of miconazole into cyclodextrins by means of supercritical carbon dioxide: influence of the addition of an acidic ternary compound. Proc. 6th Int. Symposium on Supercritical Fluids. Versailles, France (2003) 1897-1902
17. Barillaro V., Bertholet P., Henry de Hassonville S., Ziemons E., Evrard B., Delattre L., and Piel G. Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. J. Pharm. Sci. 7 (2004) 378-388
18. Barillaro V., Evrard B., Delattre L., and Piel G. Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/l-tartaric acid inclusion complex produced by supercritical carbon dioxide processing. AAPS J. 7 (2005) 149-155
19. Barillaro V., Dive G., Bertholet P., Evrard B., Delattre L., Frederich M., Ziémons E., and Piel G. Theoretical and experimental investigations of organic acids/cyclodextrin complexes and their consequences upon the formation of miconazole/previous termcyclodextrin/acid ternary inclusion complexes. Int. J. Pharm. 347 (2008) 62-70
20. Barillaro V., Dive G., Bertholet P., Evrard B., Delattre L., Ziémons E., and Piel G. Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: Molecular modeling studies. Int. J. Pharm. 342 (2007) 152-160
21. Rodier E., Lochard H., Sauceau M., Letourneau J.-J., Freiss B., and Fages J. A three-step supercritical process to improve the dissolution rate of eflucimibe. Eur. J. Pharm. Sci. 26 (2005) 184-193
22. 2 antisolvent process for drugs precipitation: from lab-scale to cGMP compliant pilot-scale. Proc. 6th Int. Symposium on Supercritical Fluids. Versailles, France (2003) 1689-1694
23. Charoenchaitrakool M., Dehghani F., and Foster N. Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin. Int. J. Pharm. 239 (2002) 103-112
24. K. Hussein, M. Türk, M. A. Wahl, Preparation and evaluation of drug/β-cyclodextrin solid inclusion complexes by supercritical fluid technology, in: Proc. 9th Meeting on Supercritical Fluids, Trieste, Italy, 2004, on CD-ROM.
25. Tozuka Y., Fujito T., Moribe K., and Yamamoto K. Ibuprofen-cyclodextrin inclusion complex formation using supercritical carbon dioxide. J. Incl. Phenom. Macrocycl. Chem. 56 (2006) 33-37
26. 2. J. Supercrit. Fluids 39 (2007) 435-443
27. Hussein K., Türk M., and Wahl M.A. Comparative evaluation of ibuprofen/beta-cyclodextrin complexes obtained by supercritical carbon dioxide and other conventional methods. Pharm. Res. 24 (2007) 585-592
28. Moribe K., Fujito T., Tozuka Y., and Yamamoto K. Solubility-dependent complexation of active pharmaceutical ingredients with trimethyl-beta-cyclodextrin under supercritical fluid condition. J. Incl. Phenom. Macrocycl. Chem. 57 (2007) 289-295
29. Hussein K., Türk M., and Wahl M.A. Drug loading into β-cyclodextrin granules using a supercritical fluid process for improved drug dissolution. Eur. J. Pharm. Sci. 33 (2008) 306-312
30. Junco S., Casimiro T., Ribeiro N., Da Ponte M.N., and Marques H.C. Optimisation of supercritical carbon dioxide systems for complexation of naproxen:β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 44 (2002) 69-73
31. Junco S., Casimiro T., Ribeiro N., Da Ponte M.N., and Marques H.C. A comparative study of naproxen:β-cyclodextrin complexes prepared by conventional methods and using supercritical carbon dioxide. J. Incl. Phenom. Macrocycl. Chem. 44 (2002) 117-121
32. Mammucari R., Dehghani F., and Foster N. Dense gas processing of micron-sized drug formulations incorporating hydroxypropylated and methylated beta-cyclodextrin. Pharm. Res. 23 (2006) 429-437
33. Marongiu B., Piras A., Porcedda S., Delogu G., Fabbri D., and Dettori M.A. Cyclodextrin inclusion compounds by supercritical carbon dioxide. Proc. 8th Meeting on Supercritical Fluids. Bordeaux, France (2002) 327-332
34. 1H NMR characterization. Carbohydr. Res. 338 (2003) 2227-2232
35. S. Junco, T. Casimiro, H. C. Marques, Inclusion complex formation of salicylic acid in β- and acetylated-β-cyclodextrins in supercritical carbon dioxide, Proc. 9th Meeting on Supercritical Fluids, Trieste, Italy, 2004, on CD-ROM.
36. Wu M., Yuguchi Y., Kumagai T., Endo T., and Hirotsu T. Nano-complex formation of cyclodextrin and azobenzene using supercritical carbon dioxide. Chem. Commun. 11 (2004) 1288-1289
37. Toropainen T., Heikkila T., Leppanen J., Matilainen L., Velaga S., Jarho P., Carlfors J., Lehto V.P., Jarvinen T., and Jarvinen K. Crystal structure changes of gamma-cyclodextrin after the SEDS process in supercritical carbon dioxide affect the dissolution rate of complexed budesonide. Pharm. Res. 24 (2007) 1058-1066
38. Toropainen T., Matilainen L., Velaga S., Heikkila T., Jarho P., Carlfors J., Lehto V.P., Jarvinen T., and Jarvinen K. Preparation of solid budesonide/γ-cyclodextrin complexes with a novel single-step supercritical fluid process (SEDS). Eur. J. Pharm. Sci. 28 (2006) S17
39. Toropainen T., Velaga S., Heikkila T., Matilainen L., Jarho P., Carlfors J., Lehto V.P., Jarvinen T., and Jarvinen K. Preparation of budesonide/gamma-cyclodextrin complexes in supercritical fluids with a novel SEDS method. J. Pharm. Sci. 95 (2006) 2235-2245
40. Bandi N., Wei W., Roberts C.B., Kotra L.P., and Kompella U.B. Preparation of budesonide- and indomethacin-hydroxypropyl-β-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process. Eur. J. Pharm. Sci. 23 (2004) 159-168
41. 2. Eur. Polym. J. 41 (2005) 2483-2487
42. Jung T.H., Park H.S., and Kwak H.S. Optimization of cholesterol removal by crosslinked beta-cyclodextrin in egg yolk. Food Sci. Biotechnol. 14 (2005) 793-797
43. Filardo G., Di Blasi M., Galia A., Ponchel A., Bricout H., Sayede A.D., and Monflier E. Peracetylated β-cyclodextrin as solubilizer of arylphosphines in supercritical carbon dioxide. J. Supercrit. Fluids 36 (2006) 173-181
44. Al-Marzouqi A.H., Shehatta I., Jobe B., and Dowaidar A. Phase solubility and inclusion complex of itraconazole with beta-cyclodextrin using supercritical carbon dioxide. J. Pharm. Sci. 95 (2006) 292-304
45. Hassan H.A., Al-Marzouqi A.H., Jobe B., Hamza A.A., and Ramadan G.A. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with β-cyclodextrin using supercritical carbon dioxide. J. Pharm. Biomed. Anal. 45 (2007) 243-250
46. Lee S.-Y., Jung I.-I., Kim J.-K., Lim G.-B., and Ryu J.-H. Preparation of itraconazole/HP-β-CD inclusion complexes using supercritical aerosol solvent extraction system and their dissolution characteristics. J. Supercrit. Fluids 44 (2008) 400-408
47. Hwang H.S., Lee M.Y., Jeong Y.T., Hong S.-S., Gal Y.-S., and Lim K.T. Complex formation of semifluorinated γ-cyclodextrin and surfactants in liquid carbon dioxide. Ind. Eng. Chem. Res. 45 (2006) 3434-3437
48. Wang B., He J., Sun D.H., Zhang R., and Han B.X. Utilization of supercritical carbon dioxide for the preparation of 3-hydroxyflavone and beta-cyclodextrin complex. J. Incl. Phenom. Macrocycl. Chem. 55 (2006) 37-40
49. Al-Marzouqi A.H., Jobe B., Dowaidar A., Maestrelli F., and Mura P. Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes-comparison with conventional methods. J. Pharm. Biomed. Anal. 43 (2007) 566-574
50. Al-Marzouqi A.H., Jobe B., Corti G., Cirri M., and Mura P. Physicochemical characterization of drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. J. Incl. Phenom. Macrocycl. Chem. 57 (2007) 223-231
51. Jun S.W., Kim M.-S., Kim J.-S., Park H.J., Lee S., Woo J.-S., and Hwang S.-J. Preparation and characterization of simvastatin/hydroxypropyl-β-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur. J. Pharm. Biopharm. 66 (2007) 413-421
52. Galia A., Navarre E.C., Scialdone O., Ferreira M., Filardo G., Tilloy S., and Monflier E. Complexation of phosphine ligands with peracetylated beta-cyclodextrin in supercritical carbon dioxide: Spectroscopic determination of equilibrium constants. J. Phys. Chem. B 111 (2007) 2573-2578
53. Blanch G.P., Ruiz del Castillo M.L., del Mar Cajaa M., Pérez-Méndez M., and Sánchez-Cortés S. Stabilization of all-trans-lycopene from tomato by encapsulation using cyclodextrins. Food Chemistry 105 (2007) 1335-1341
54. Bouchard A., Jovanovic N., Hofland G.W., Jiskoot W., Mendes E., Crommelin D.J.A., and Witkamp G.-J. Supercritical fluid drying of carbohydrates: Selection of suitable excipients and process conditions. Eur. J. Pharm. Biopharm. 68 (2008) 781-794
55. Jovanovic N., Bouchard A., Hofland G.W., Witkamp G.-J., Crommelin D.J.A., and Jiskoot W. Stabilization of IgG by supercritical fluid drying: Optimization of formulation and process parameters. Eur. J. Pharm. Biopharm. 68 (2008) 183-190
56. Bounaceur A., Rodier E., and Fages J. Study of the maturation of a ketoprofen/β-cyclodextrin mixture, assisted by supercritical fluid. J. Supercrit. Fluids 41 (2007) 429-439
57. Al-Marzouqi A.H., Solieman A., Shehadi I., and Adem A. Influence of the preparation method on the physicochemical properties of econazole-beta-cyclodextrin complexes. J. Incl. Phenom. Macrocycl. Chem 60 (2008) 85-93
58. Brogden R.N., Heel R.C., Speight T.M., and Avery G.S. Piroxicam: a review of its pharmacological properties and therapeutic efficacy. Drugs 22 (1981) 165-187
59. Deroubaix X., Stockis A., Allemon A.M., Lebacq E., Acerbi D., and Ventura P. Oral bioavailability of CHF1194, an inclusion complex of piroxicam and β-cyclodextrin, in healthy subjects under single dose and steady-state conditions. Eur. J. Clin. Pharmacol. 47 (1995) 531-536
60. Woodcock B.G., Acerbi D., Merz P.G., Rietbrock S., and Rietbrock N. Supermolecular inclusion of piroxicam with β-cyclodextrin: pharmacokinetic properties in man. Eur. J. Rheumatol. Inflamm. 12 (1993) 12-28
61. Acerbi D., Bovis G., Carli F., Pasini M., Pavesi L., and Peveri T. Biopharmaceutical optimisation of β-cyclodextrin inclusion compounds. Drug Invest. 2 (1990) 29-36
62. Redenti E., Peveri T., Zanol M., Ventura P., Gnappi G., and Montenero A. A Study on the differentiation between amorphous piroxicam:β-cyclodextrin complex and a mixture of the two amorphous components. Int. J. Pharm. 129 (1996) 289-294
63. Van Hees T., Piel G., Henry De Hassonville S., Evrard B., and Delattre L. Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry. Eur. J. Pharm. Sci. 15 (2002) 347-353
64. Macnaughton S.J., Kikic I., Foster N., Alessi P., Cortesi A., and Colombo I. Solubility of anti-inflammatory drugs in supercritical carbon dioxide. J. Chem. Eng. Data 41 (1996) 1083-1086
65. Wilke C.R., and Chang P. Correlation of diffusion coefficient in dilute solutions. AIChE J. 1 (1955) 264